The article examines the effectiveness of remote monitoring and the evaluation of facts about patients with hematologic malignancies using telemedicine based on SMART technologies. The project was carried out in the Department of Haematooncology of the University Hospital Ostrava. Its objective was to test the efficacy of telemedicine in the treatment of patients with blood cancer. The cost-benefit analysis method was used to evaluate effectiveness, which also confirmed the feasibility of using this method to evaluate the costs and benefits of implementing specific medical projects. The conducted analysis demonstrated the effectiveness of using telemedicine procedures in the treatment of these patients, both in terms of quantifiable and non-quantifiable impacts on the Czech Republic's health system. This was mainly due to a large shortening of the length of the hospitalisation period for patients with problems whose deterioration was discovered by remote monitoring and their treatment could begin promptly. The shortening of the hospitalization period was achieved by around 40%. As a result, the complexity of treatment has been greatly reduced, benefiting both the hospital and, most importantly, the patient. With this prevention, the patient's chances of dying are reduced, as he or she is less likely to develop severe septic diseases. The total average financial savings of the Czech Republic's entire health care system for a patient who does not become septic due to a delayed response to deteriorating health only in hospitalisation, treatment, and medications is approximately USD 2,800.

Department of Economics and Public Administration Silesian University in Opava School of Business Administration in Karvina Karvina Czech Republic

Department of Haematooncology University Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic

Department of Haematooncology University Hospital Ostrava and Faculty of Science University of Ostrava Ostrava Czech Republic

Zobrazit více v PubMed

Koščík M., Mayer J. (August 2021). National hemato-oncology program of the Czech Republic, August 2021 [online]. Copyright © [cit. 01.02.2023]. Available from: https://www.hematology.cz/wp-content/uploads/2022/01/Narodni_ hematoonkologicky_program_CR_2021-08-13.pdf

Klastersky J., de Naurois J., Rolston K., Rapoport B., Maschmeyer G., Aapro M., et al. (2016). Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Annals of Oncology 27, v111–v118. doi: 10.1093/annonc/mdw325 PubMed DOI

White L., and Ybarra M. (2014). Neutropenic fever. Emerg. Med. Clin. North Am. 32, 549–561. doi: 10.1016/j.emc.2014.04.002 PubMed DOI

Ko B.S., Ahn S., Lee Y.-S., Kim W.Y., Lim K.S., and Lee J.-L. (2015). Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia. Support Care Cancer 23, 2799–2804. doi: 10.1007/s00520-015-2645-5 PubMed DOI

Rosa R.G., and Goldani L.Z. (2014). Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob. Agents Chemother. 58, 3799–3803. doi: 10.1128/AAC.02561-14 PubMed DOI PMC

Kvedar J., Coye M.L., and Everett W. (2014). Connected Health: A Review Of Technologies And Strategies To Improve Patient Care With Telemedicine And Telehealth. Health Affairs 2014 33:2, 194–199. doi: 10.1377/hlthaff.2013.0992 PubMed DOI

Jagannath S., Mikhael J., Nadeem O., Raje N. (2021). Digital Health for Patients With Multiple Myeloma: An Unmet Need. JCO Clinical Cancer Informatics 5(5), 1096–1105. doi: 10.1200/CCI.20.00145 PubMed DOI

Sanjeev P. Bhavnani, Jagat Narula Partho P. Sengupta , Mobile technology and the digitization of healthcare, European Heart Journal, Volume 37, Issue 18, 7 May 2016, Pages 1428–1438, doi: 10.1093/eurheartj/ehv770 PubMed DOI PMC

Turečková K. and Nevima J., 2020. The Cost Benefit Analysis for the Concept of a Smart City: How to Measure the Efficiency of Smart Solutions? Sustainability, 12(7). doi: 10.3390/su12072663 DOI

Hradská T., Popková T., Skořupová M., Mihalyova J., Jelínek T., Lančová J., et al. (2022). Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine. Cancer Management and Research Volume 14, 1655–1661. doi: 10.2147/CMAR.S348923 PubMed DOI PMC

Slavík J. Smart City v Praxi: Jak pomocí moderních technologií vytvářet město příjemné k životu a přátelské k podnikání; Profi Press: Praha, Czech Republic, 2017.

Sieber, P. Finanční a socioekonomické hodnocení projektů (Metodická příručka). [online]. Copyright © [cit. 01.02.2023]. Available online: https://www.ropstrednicechy.cz/.

Organisation for Economic Co-operation and Development. Cost–benefit analysis and the environment: Recents developments. In Executive Summary; OECD: Paris, France, 2006.

European Union. European Commisssion, Guide to Cost-Benefit Analysis of Investment Projects; European Union: Luxembourg, 2015, doi: 10.2776/97516 DOI

Ochrana F. Hodnocení veřejných zakázek a veřejných projektů, 2nd ed.; ASPI publishing: Praha, Czech Republic, 2001.

Turečková K.; Nevima J. SMART CITY concept in the Czech. Republic. In Proceedings of the 29th EBES Conference, Lisbon, Portugal, October 10–12 2019; pp. 1039–1048.

Borseková K.; Vaňová A.; Vitálišová K. Smart Specialization for Smart Spatial Development: Innovative Strategies for Building Competitive Advantages in Tourism in Slovakia. Socio-Econ. Plan. Sci. 2017, 58, 39–50.

Marešová P. Měření ve Znalostním Management—Aplikace Metody Cost Benefit Analysis; Gaudeaumus: Hradec Králové, Czech Republic, 2012.